A new 5-HT3 receptor ligand.: II.: Structure-activity analysis of 5-HT3 receptor agonist action in the gut

被引:0
|
作者
Yamada, M [1 ]
Sato, Y [1 ]
Kobayashi, K [1 ]
Konno, F [1 ]
Soneda, T [1 ]
Watanabe, T [1 ]
机构
[1] Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Kohoku Ku, Yokohama, Kanagawa 222, Japan
关键词
1-allyl-1-methyl-4-(2-benzoxazolyl)piperazinium iodide (CP2289); 5-HT3; receptor; agonist;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several modified 2-piperazinyl benzoxazole derivatives, which exhibit an agonistic effect on gastrointestinal motility, were synthesized and their effects on the contraction of guinea-pig ileum were examined, The quaternary piperazinyl benzoxazole structure has a restricted conformation and stereostructure compared to those of the other 5-HT3 receptor agonists, serotonin and meta-chlorophenylbiguanide. The mutual positions of the aromatic ring, nitrogen atom and terminal amine are considered to form the pharmacophore of the 5-HT3 receptor agonist in the gut. In the serotonin-evoked reflex bradycardia [Bezold-Jarisch (B-J) reflex] inhibition test using rats the B-J reflex-inducing ratio was different for each synthesized compound. These results suggest that, in these 5-HT3 receptor agonists, the substituents of the benzoxazole ring influence the B-J reflex-inducing activity in rats.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [21] Allosteric modulation of the 5-HT3 receptor
    Davies, Paul A.
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (01) : 75 - 80
  • [22] Functional Reconstitution of the 5-HT3 Receptor
    Sanchez, Uriel Lopez
    Zarkadas, Eleftherios
    Schoehn, Guy
    Nury, Hugues
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 582A - 582A
  • [23] The 5-HT3 receptor as a therapeutic target
    Thompson, Andrew J.
    Lummis, Sarah C. R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (04) : 527 - 540
  • [24] Additional binding mechanism of palonosetron to the 5-HT3 receptor versus first generation 5-HT3 receptor antagonists
    Rojas, C.
    Stathis, M.
    Alt, J.
    Rubenstein, E.
    Cantoreggi, S.
    Sebastiani, S.
    Slusher, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] MECHANISM OF THE ANTIEMETIC ACTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS
    TYERS, MB
    FREEMAN, AJ
    ONCOLOGY, 1992, 49 (04) : 263 - 268
  • [26] Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor
    Thompson, AJ
    Chau, PL
    Chan, SL
    Lummis, SCR
    BIOPHYSICAL JOURNAL, 2006, 90 (06) : 1979 - 1991
  • [27] The 5-HT3 receptor - the relationship between structure and function
    Barnes, Nicholas M.
    Hales, Tim G.
    Lummis, Sarah C. R.
    Peters, John A.
    NEUROPHARMACOLOGY, 2009, 56 (01) : 273 - 284
  • [28] Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT3 Receptor Ligands
    Verheij, Mark H. P.
    Thompson, Andrew J.
    van Muijlwijk-Koezen, Jacqueline E.
    Lummis, Sarah C. R.
    Leurs, Rob
    de Esch, Iwan J. P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8603 - 8614
  • [29] 5-HT3 RECEPTOR ANTAGONISTS - A NEW CLASS OF ANTIEMETICS
    不详
    LANCET, 1987, 1 (8548): : 1470 - 1471
  • [30] SYNTHESIS AND 5-HT3 RECEPTOR AGONIST ACTIVITY OF ARYLUREAS DERIVED FROM HISTAMINE
    BERMUDEZ, J
    BOYLAND, P
    KING, FD
    SUMMERSELL, RJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (02) : 205 - 208